244 related articles for article (PubMed ID: 35428505)
1. Mohs Micrographic Surgery for the Treatment of Cutaneous Melanomas of the Head and Neck.
Jacobsen ES; Soleymani T
Oral Maxillofac Surg Clin North Am; 2022 May; 34(2):263-271. PubMed ID: 35428505
[TBL] [Abstract][Full Text] [Related]
2. Cutaneous head and neck melanoma treated with Mohs micrographic surgery.
Bricca GM; Brodland DG; Ren D; Zitelli JA
J Am Acad Dermatol; 2005 Jan; 52(1):92-100. PubMed ID: 15627086
[TBL] [Abstract][Full Text] [Related]
3. Mohs Micrographic Surgery Using MART-1 Immunostain in the Treatment of Invasive Melanoma and Melanoma In Situ.
Valentín-Nogueras SM; Brodland DG; Zitelli JA; González-Sepúlveda L; Nazario CM
Dermatol Surg; 2016 Jun; 42(6):733-44. PubMed ID: 27158886
[TBL] [Abstract][Full Text] [Related]
4. The use of Mohs micrographic surgery (MMS) for melanoma in situ (MIS) of the trunk and proximal extremities.
Stigall LE; Brodland DG; Zitelli JA
J Am Acad Dermatol; 2016 Nov; 75(5):1015-1021. PubMed ID: 27473456
[TBL] [Abstract][Full Text] [Related]
5. Mohs micrographic surgery for the treatment of primary cutaneous melanoma.
Zitelli JA; Brown C; Hanusa BH
J Am Acad Dermatol; 1997 Aug; 37(2 Pt 1):236-45. PubMed ID: 9270510
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcomes of Mohs micrographic surgery for invasive melanoma of the trunk and proximal portion of the extremities.
Burnett ME; Brodland DG; Zitelli JA
J Am Acad Dermatol; 2021 Mar; 84(3):661-668. PubMed ID: 32763327
[TBL] [Abstract][Full Text] [Related]
7. Systematic review and meta-analysis of local recurrence rates of head and neck cutaneous melanomas after wide local excision, Mohs micrographic surgery, or staged excision.
Bittar PG; Bittar JM; Etzkorn JR; Brewer JD; Aizman L; Shin TM; Sobanko JF; Higgins HW; Giordano CN; Cohen JV; Pride R; Wan MT; Leitenberger JJ; Bar AA; Aasi S; Bordeaux JS; Miller CJ
J Am Acad Dermatol; 2021 Sep; 85(3):681-692. PubMed ID: 33961921
[TBL] [Abstract][Full Text] [Related]
8. Melanomas of the head and neck have high-local recurrence risk features and require tissue-rearranging reconstruction more commonly than basal cell carcinoma and squamous cell carcinoma: A comparison of indications for microscopic margin control prior to reconstruction in 13,664 tumors.
Fix W; Etzkorn JR; Shin TM; Howe N; Bhatt M; Sobanko JF; Miller CJ
J Am Acad Dermatol; 2021 Aug; 85(2):409-418. PubMed ID: 30458206
[TBL] [Abstract][Full Text] [Related]
9. Mohs micrographic surgery: a cost analysis.
Cook J; Zitelli JA
J Am Acad Dermatol; 1998 Nov; 39(5 Pt 1):698-703. PubMed ID: 9810885
[TBL] [Abstract][Full Text] [Related]
10. Benefit of Mohs Micrographic Surgery Over Wide Local Excision for Melanoma of the Head and Neck: A Rational Approach to Treatment.
Demer AM; Vance KK; Cheraghi N; Reich HC; Lee PK
Dermatol Surg; 2019 Mar; 45(3):381-389. PubMed ID: 30550523
[TBL] [Abstract][Full Text] [Related]
11. Mohs micrographic surgery for melanoma: A prospective multicenter study.
Ellison PM; Zitelli JA; Brodland DG
J Am Acad Dermatol; 2019 Sep; 81(3):767-774. PubMed ID: 31150700
[TBL] [Abstract][Full Text] [Related]
12. Surgical margins for excision of primary cutaneous melanoma.
Zitelli JA; Brown CD; Hanusa BH
J Am Acad Dermatol; 1997 Sep; 37(3 Pt 1):422-9. PubMed ID: 9308558
[TBL] [Abstract][Full Text] [Related]
13. Treating melanoma in situ and lentigo maligna with Mohs micrographic surgery in Australia.
Foxton GC; Elliott TG; Litterick KA
Australas J Dermatol; 2019 Feb; 60(1):33-37. PubMed ID: 29932208
[TBL] [Abstract][Full Text] [Related]
14. Excision margins for melanoma in situ on the head and neck-A single-center 10-year retrospective review of treatment with Mohs micrographic surgery.
Tate JA; Matsumoto A; Greif C; Lim J; Nijhawan RI; Srivastava D
J Am Acad Dermatol; 2024 Jun; 90(6):1226-1231. PubMed ID: 38253130
[TBL] [Abstract][Full Text] [Related]
15. Improved overall survival of melanoma of the head and neck treated with Mohs micrographic surgery versus wide local excision.
Hanson J; Demer A; Liszewski W; Foman N; Maher I
J Am Acad Dermatol; 2020 Jan; 82(1):149-155. PubMed ID: 31473297
[TBL] [Abstract][Full Text] [Related]
16. Recurrence Rate for Melanoma Excised by Mohs Micrographic Surgery Without Immunostaining.
Vieira C; Jennings T; Renzi MA; Lawrence N; Decker A
Dermatol Surg; 2022 May; 48(5):492-497. PubMed ID: 35298442
[TBL] [Abstract][Full Text] [Related]
17. Desmoplastic melanoma treated with wide local excision or Mohs micrographic surgery: Rates of positive margins, local recurrence, and repeat surgeries.
Ran NA; Nugent ST; Veerabagu SA; Chu EY; Modi MB; Sobanko JF; Etzkorn JR; Shin TM; Higgins HW; Giordano CN; McMurray SL; Walker JL; Stull CM; Miller CJ
J Am Acad Dermatol; 2022 Dec; 87(6):1376-1378. PubMed ID: 35963290
[No Abstract] [Full Text] [Related]
18. Outcomes in intermediate-risk squamous cell carcinomas treated with Mohs micrographic surgery compared with wide local excision.
Xiong DD; Beal BT; Varra V; Rodriguez M; Cundall H; Woody NM; Vidimos AT; Koyfman SA; Knackstedt TJ
J Am Acad Dermatol; 2020 May; 82(5):1195-1204. PubMed ID: 31887322
[TBL] [Abstract][Full Text] [Related]
19. Mohs micrographic surgery for melanoma: a case series, a comparative study of immunostains, an informative case report, and a unique mapping technique.
Albertini JG; Elston DM; Libow LF; Smith SB; Farley MF
Dermatol Surg; 2002 Aug; 28(8):656-65. PubMed ID: 12174054
[TBL] [Abstract][Full Text] [Related]
20. Mohs Micrographic Surgery for Melanoma: Evidence, Controversy, and a Critical Review of Excisional Margin Guidelines.
Brodland DG
Dermatol Clin; 2023 Jan; 41(1):79-88. PubMed ID: 36410985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]